drugset

drugset / Trial / NCT00584805

Safety and Immunogenicity Study of Eastern Equine Encephalitis (EEE) Vaccine

NCT00584805 ↗

Phase 2 Completed 138 enrolled U.S. Army Medical Research and Development Command

NaSingle-groupOpen-labelPrevention

Summary

This study is designed to determine the safety and immunogenicity of Eastern Equine Encephalitis (EEE) Vaccine.

Timeline

Start: 2008-06-03
Primary completion: 2016-06-27
Completion: 2017-06

Publications

Schultz JS, Sparks H, Beckham JD. Arboviral central nervous system infections. Curr Opin Infect Dis. 2021 Jun 1;34(3):264-271. doi: 10.1097/QCO.0000000000000729.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	TSI GSD 104	Unknown	0.1 ml	Subcutaneous

Indications